NCT02719028 - Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

September 27, 2018

Study Completion Date

March 31, 2019

Conditions

Hyperlipidemias

Interventions

DRUG

Antroquinonol

Antroquinonol will be provided as capsules of 50 mg

DRUG

placebo

The matching placebo will be packaged as Antroquinonol with appearance identical in all aspects, however, don't have the active compound(antroquinonol)

Trial Locations (6)

Unknown

Chang Gung Memorial Hospital, Linkou branch, New Taipei City

Far Eastern Memorial Hospital, New Taipei City

China Medical University Hospital, Taichung

National Cheng Kung University Hospital, Tainan City

National Taiwan University Hospital, Taipei

Taipei Veterans General Hospital, Taipei